1. (1) A presenter seeking to dispel false or misleading information about medical cannabis may include the false or misleading information in educational material if they also include a true statement regarding lawful cannabis use in Utah that dispels the false or misleading information.
2. (2) Educational material that relates to the use of medical cannabis products shall include information relating to side effects, consequences, contraindications, and effectiveness of medical cannabis, and ensure that information relating to effectiveness is not presented in greater scope, depth, or detail than information relating to side effects, consequences, and contraindications.
3. (3) The department will evaluate educational materials based on factors such as typography, layout, contrast, headlines, paragraphing, white space, and other techniques used to achieve emphasis.

4. (4) Educational material is false or otherwise misleading if it:

   1. (a) contains a representation that a cannabis strain, brand, or product is more effective, useful in a broader range of conditions or patients, or safer than another drug or treatment, including other cannabis strains or products, unless the claim has been demonstrated by substantial evidence or substantial clinical data;
   2. (b) uses a quote or paraphrases information out of context or without citing conflicting information from the same source in a manner that conveys a false or misleading idea;
   3. (c) uses a study on individuals without a qualifying medical condition without disclosing that the subjects were not suffering from a qualifying medical condition;
   4. (d) uses data to present a cannabis product favorably that is derived from patients treated with a different product or with dosages different from those legal in Utah;
   5. (e) contains favorable information or conclusions from a study that is inadequate in design, scope, or conduct to furnish significant support for the information or conclusions;
   6. (f) fails to disclose the source of the material with sufficient detail to enable participants to locate the material independently; or
   7. (g) fails to disclose that a study has not been subject to the peer review process.

5. (5) Educational material may not include:

   1. (a) unsubstantiated health claims or claims without substantial evidence or substantial clinical data;
   2. (b) information that encourages cannabis use for a non-qualifying condition;

   3. (c) unprofessional terms, slang, phrasing, or verbiage associated with recreational cannabis use, unless those terms are necessary to:

      1. (i) clarify or provide information valuable to the educational event participants, such as law enforcement officers;
      2. (ii) identify and educate individuals on common terms used by patients and other individuals to refer to cannabis; and
      3. (iii) present these terms in that context;
   4. (d) images resembling cartoon or fictional character whose target audience is children or minors;
   5. (e) content, symbols, or imagery that the cannabis production establishment knows or should know appeals to children;
   6. (f) imagery featuring a person using the product in any way;
   7. (g) statements that encourage, promote, or otherwise create an impression that use of cannabis is legal or acceptable to use in a manner except as specifically authorized under Title 26B, Chapter 4, Part 2 Cannabinoid Research and Medical Cannabis Act;

   8. (h) statements that recreational cannabis use has any potential health or therapeutic benefits, or that recreational use or possession is legal in Utah or under federal law;

      1. (i) content dismissive of medical cannabis approved to treat a qualifying medical condition;
   9. (j) content promoting consumption exceeding the recommended dosage;

   10. (k) content targeting out-of-state customers;

       1. (l) statements that falsely disparage a competitor's product; or
   11. (m) statement, design, or representation, picture or illustration that is obscene or indecent.

KEY: cannabis, educational event, cannabis establishment production, medical cannabis pharmacy, educational material, standards

Date of Last Change: October 22, 2025

Authorizing, and Implemented or Interpreted Law: 4-41a-403; 4-41a-1104